Collection of Blood, Tissue and Urine From Patients With Cancer
18 Years
N/A
Both
Neoplasms
Trial Information
Collection of Blood, Tissue and Urine From Patients With Cancer
Patients with a prior diagnosis of malignancy or refractory cancer will be evaluated in the
Medical Oncology Clinic, NCI or Interventional Radiology, NIH Clinical Center. Blood or
urine samples may be collected at the initial visit and at follow-up visits. The specimens
will be processed and stored in one or more of these locations for use in research efforts:
Laboratory of Tumor Immunology and Biology, Clinical Pharmacology Program, NCI
Frederick, Dr. Tito Fojo's laboratory and Dr. Jane Trepel's Laboratory.
Inclusion Criteria
- INCLUSION CRITERIA:
Patients 18 years of age and older are eligible.
Patients must have a performance status of ECOG 0, 1, 2, or 3 for admission to this
protocol.
Patients with malignancy are eligible.
INCLUSION FOR APHERESIS:
Hemoglobin greater than or equal to 10 mg/dL and platelet count > 75,000/mm(3)
Weight greater than 25 kg
HIV negative
Prothrombin Time - within normal limits
Partial Thromboplastin Time - within normal limits
Medically indicated central line in place or adequate peripheral venous access
EXCLUSION CRITERIA:
Children will not be eligible.
Type of Study:
Observational
Study Design:
N/A
Principal Investigator
James L Gulley, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
National Cancer Institute (NCI)
Authority:
United States: Federal Government
Study ID:
020179
NCT ID:
NCT00034216
Start Date:
April 2002
Completion Date:
Related Keywords:
- Neoplasms
- Suppressor Cells
- T Cells
- CD4+/CD25+ Cells
- Cancer
- Malignancy
- Blood Sample
- Neoplasms
Name | Location |
|---|---|
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda, Maryland 20892 |
